Exploratory Safety Study of ALD518 in Subjects With Steroid-refractory Acute Graft Versus Host Disease (GVHD)
Clinical trial NCT01530256 · TERMINATED
Trial details
- NCT number
- NCT01530256
- Sponsor
- CSL Behring
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2013-03-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.